Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Ascent

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Mar 15, 2021 2:12pm

211 Views

Post# 32799960

RE:RE:Ascent

Take some initiative RixPix. Don't expect others to cater to your needs. Jumbo text looks ridiculous to the non old timers.

Pinch-to-zoom refers to the multi-touch gesture that zooms in or out of the displayed content on a device with a touch screen. These devices include a smartphones and tablets. To use pinch-to-zoom, touch two fingers on the touch screen, and move them apart to zoom in, or together to zoom out

rixpix wrote: Hey DonkeyFeathers...
Font size below is the perfect size for us oldtimes when you post.
CHeers!!!

Charly50 wrote: There will be several news releases in April.
That is why I believe that the next ascent has begun.
I, too, believe that it will be expensive for BIG PHARMA.
I see the free float as a blessing. So Big Pharma can already ma ma a few cheap
Sernova shares. Clearly, this leads to rising prices.Today Credential, BMO and UBS on the buyer side.There is now only Pershing missing....... and the rocket launches.